CA
NZ
UK
AU
IND
US
INOVIO Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company developing DNA medicines targeting HPV-related diseases, cancer, and infectious diseases, announced its plans to conduct a public offering of its common stock. All shares in the offering will be sold by the company, which will also grant …
Beyond Meat, Inc. (NASDAQ:BYND)announced results for the quarter ended September 27, 2025. Net revenues totaled 70.2M USD, down 13.3% from 81.0M USD in Q3 2024. The decline was primarily driven by a 10.3% decrease in product volume sold and a 3.5% drop in net …
TEN Holdings, Inc. (NASDAQ:XHLD), via its subsidiary Ten Events, Inc., reported financial results for the quarter ended September 30, 2025. Revenue for Q3 2025 totaled 543,000 USD, a 1.5% increase from 535,000 USD in the same quarter of 2024. The growth was largely driven …
Workhorse Group, Inc. (NASDAQ:WKHS)reported results for the third quarter ending September 30, 2025. Net sales for Q3 2025 totaled 2.4M USD, slightly below 2.5M USD in Q3 2024, reflecting lower truck sales, partially offset by recognition of seven vehicles from deferred revenue. Cost of …
Precision BioSciences, Inc. (NASDAQ:DTIL)reported new findings from its ongoing Phase 1 ELIMINATE-B study of PBGENE-HBV at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2025. PBGENE-HBV is an in vivo gene editing therapy designed to target HBV cccDNA and …
Commercial Vehicle Group(NASDAQ:CVGI)announced financial results for the third quarter ended September 30, 2025. Revenues from continuing operations reached 152.5M USD, down 11.2% from 171.8M USD in the same quarter of 2024, primarily due to softer demand in North America. Gross profit slightly decreased to …
NioCorp Developments Ltd. (NASDAQ:NB)announced the completion of its land acquisition in Johnson County, Nebraska, related to the Elk Creek Critical Minerals Project. Following this transaction, NioCorp owns a full square mile, known as a "Section," where the company plans to develop both its underground …
Microvast Holdings, Inc. (NASDAQ:MVST)announced its unaudited condensed consolidated results for the third quarter ended September 30, 2025. The company reported record Q3 revenue of 123.3M USD, up 21.6% from 101.4M USD in Q3 2024. Gross margin improved to 37.6% from 33.2% year-over-year, with a …
Willis Towers WatsonPlc (NASDAQ:WTW)reported that total assets under management for the world’s 500 largest asset managers reached 139.9T USD at the end of 2024, marking a 9.4% increase from 2023. This surpasses the previous record set in 2021, driven primarily by North American managers, …
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV)released its financial results for Q3 2025 and shared an operational update. The US launch of EKTERLY® (sebetralstat) began on July 7, 2025. By October 31, 2025, the company had received 937 patient start forms and activated 423 unique prescribers.
Please wait processing your request...